Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NCK, officially NIELS CLAUSON-KAAS A/S, is a Denmark-based pharmaceutical services company focused on process development, analytical development, and cGMP manufacturing of active pharmaceutical ingredients and advanced intermediates for biotech and pharmaceutical clients. The company operates as a specialized small-molecule chemistry partner supporting programs from discovery through preclinical, clinical, and commercial supply. Its capabilities include synthesis, project management, analytical testing, quality assurance, and operation of a multi-purpose GMP pilot plant. NCK traces its origins to the organic synthesis work of chemist Niels Clauson-Kaas and has built a long-standing reputation in applied chemistry and custom API manufacturing. The business appears to be a niche contract development and manufacturing organization rather than a therapeutics developer with an internal drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NCK.